[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100477051":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":15,"locations":21,"responsibleParty":36,"collaborators":7,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":7,"acronym":7,"eligibilityCriteria":43,"healthyVolunteers":40,"sex":44,"minAge":7,"maxAge":7,"enrollmentInfo":7,"targetDuration":7,"studyType":45,"phases":7,"briefSummary":46,"conditions":47,"keywords":7,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":7,"completionDateStruct":7,"leadSponsor":53,"locationsCount":54},{"fullName":5,"class":6},"Matrix Biomed, Inc.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DRUG","Tempol","Tempol will be given as an adjunct to chemotherapy.",[14],"MBM-0-1 MBM-02",[16],{"name":17,"role":18,"phone":19,"phoneExt":7,"email":20},"Benji Crane","CONTACT","6264376506","bjcrane@matrixbiomed.com",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":7},"UCHealth University of Colorado Cancer Center - Anschutz Medical Campus","AVAILABLE","Aurora","Colorado","80045","United States","US",{"type":31,"coordinates":32},"Point",[33,34],-104.83192,39.72943,{"lat":34,"lon":33},{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100477051","treatment-of-metastatic-cancer-in-terminally-diagnosed-patients-100477051",false,"NCT05491928","Treatment of Metastatic Cancer in Terminally Diagnosed Patients","Inclusion Criteria:\n\n* metastatic terminally diagnosed cancer\n\nExclusion Criteria:\n\n\\-","ALL","EXPANDED_ACCESS","The objective is to provide terminally diagnosed patients with a last line of treatment while improving overall quality of life. Tempol can be added to any chemotherapy regimen to potentially reduce side effects and overcome chemoresistance.",[48],"Metastatic Cancer","2022-08-31",{"date":51,"type":52},"2022-09-01","ACTUAL",{"name":5,"class":6},1]